Recruiting NA Human Papillomavirus Infection

New treatment option for Human Papillomavirus Infection

Official title Digital Telecytology for Triage of HPV-Positive Women in Cameroon

ClinicalTrials.gov ID: NCT07550010

What this study is testing

What it's testing
This study evaluates the diagnostic accuracy and feasibility of a same-day cervical cancer screening strategy using HPV self-sampling followed by digital telecytology triage among HPV-positive women in Cameroon. Women aged 30-49 years (or 25-49 years if HIV-positive) will undergo primary HPV testing using the GeneXpert system.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 25 to 50, women only. Healthy volunteers may be eligible.

You may be able to join if

  • HIV-negative women aged 30-49 and HIV-positive women aged 25-49 years old
  • Ability to understand study procedures and accepting voluntarily to participate by signing an informed consent form (ICF).

You likely can't join if

  • Pregnancy at the time of screening
  • Previous hysterectomy
  • Known cervical cancer
  • Symptoms of cervical cancer (e.g. metrorrhagia, known pelvic mass)
  • Conditions that can interfere with visualization of the cervix
  • Severe pre-existing medical conditions (e.g. advanced cancer, terminal renal failure)
See the full eligibility criteria
Who can join
  • HIV-negative women aged 30-49 and HIV-positive women aged 25-49 years old
  • Ability to understand study procedures and accepting voluntarily to participate by signing an informed consent form (ICF).
What rules you out
  • Pregnancy at the time of screening
  • Previous hysterectomy
  • Known cervical cancer
  • Symptoms of cervical cancer (e.g. metrorrhagia, known pelvic mass)
  • Conditions that can interfere with visualization of the cervix
  • Severe pre-existing medical conditions (e.g. advanced cancer, terminal renal failure)
  • Women who are not able to comply with the study protocol.

The study team makes the final eligibility decision.

Where it's taking place

  • Yaoundé, Cameroon

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 25 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Yaoundé, Cameroon. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.